These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30519638)

  • 21. Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B-cell lymphoma cells and their association with clinical features.
    Kobayashi K; Yamaguchi M; Miyazaki K; Imai H; Yokoe K; Ono R; Nosaka T; Katayama N
    Cancer Med; 2016 Aug; 5(8):1802-9. PubMed ID: 27184832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
    Colomo L; López-Guillermo A; Perales M; Rives S; Martínez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E
    Blood; 2003 Jan; 101(1):78-84. PubMed ID: 12393466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx.
    Ma D; Ma Y; Ma Y; Liu J; Gu Y; Liu N; Xiang C; Liu H; Sang W
    Front Oncol; 2022; 12():941347. PubMed ID: 36081566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
    Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
    Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China.
    Shen Z; Wang L; Zhang B; Li T; Li D; He C; Xue Y; Wang Y; Li B; Liu Q; Zhang H; Gu W; Wang F; Wang C; Shi Y; Ye J; Zhu T; Miao Y; Huang S; Sang W
    Front Oncol; 2021; 11():754180. PubMed ID: 34804942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.
    Thakral B; Medeiros LJ; Desai P; Lin P; Yin CC; Tang G; Khoury JD; Hu S; Xu J; Loghavi S; Hu B; Oki Y; Li S
    Eur J Haematol; 2017 Apr; 98(4):415-421. PubMed ID: 28039906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinicopathologic and prognosis study of Epstein-Barr virus positive diffuse large B-cell lymphoma in west-southern China].
    Ye YX; Zhang WY; Li GD; Liu WP; Liu YM; Lin L; Liao DY; Guo J; Xie CY; Jiang WJ; Liu L; Zhang SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):652-7. PubMed ID: 25286694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CD5 expression is an adverse prognostic factor in diffuse large B-cell lymphoma].
    Zheng Y; Ma XB; Jiang J; Wang YP
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):156-60. PubMed ID: 22800477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Meng B; Zhang H
    Hematol Oncol; 2019 Oct; 37(4):360-367. PubMed ID: 31359442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare CD5-positive subgroup of diffuse large B-cell lymphoma - clinical, morphological and immunophenotypic features in Polish patients.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Kulczycka E; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2016; 67(3):235-243. PubMed ID: 28155972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
    Tagawa H; Suguro M; Tsuzuki S; Matsuo K; Karnan S; Ohshima K; Okamoto M; Morishima Y; Nakamura S; Seto M
    Blood; 2005 Sep; 106(5):1770-7. PubMed ID: 15886317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sub-classification of diffuse large B-cell lymphoma by semi-quantification of the CD5 expression with flow cytometric analysis].
    Manabe N; Yamaoka G; Ohnishi H; Arai T; Nakaishi H; Kajikawa T; Kubota Y; Tanaka T; Kitanaka A; Waki M; Kawakami K; Nagai M; Ishida T; Taminato T
    Rinsho Byori; 2002 Sep; 50(9):906-11. PubMed ID: 12386970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma].
    Zhao Q; Fu WJ; Zhang CY; Du J; Xi H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):737-40. PubMed ID: 24103868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
    Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
    Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R
    Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.
    Kong SY; Cho EH; Woo HY; Park Q; Ko YH; Kim SH
    J Korean Med Sci; 2004 Dec; 19(6):815-9. PubMed ID: 15608391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.
    Shimono J; Miyoshi H; Kiyasu J; Sato K; Kamimura T; Eto T; Miyagishima T; Nagafuji K; Teshima T; Ohshima K
    Br J Haematol; 2017 Sep; 178(5):719-727. PubMed ID: 28493517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
    Ishikawa E; Kato S; Shimada K; Tanaka T; Suzuki Y; Satou A; Kohno K; Sakakibara A; Yamamura T; Nakamura M; Miyahara R; Goto H; Nakamura S; Hirooka Y
    Cancer Med; 2018 Dec; 7(12):6051-6063. PubMed ID: 30449068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.